<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39353811</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1871-403X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Obesity research &amp; clinical practice</Title><ISOAbbreviation>Obes Res Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Overweight and obesity code (E66) trends and predictors in Canada: Cross-sectional analysis of Discharge Abstract Data (DAD), 2018-2022.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1871-403X(24)00390-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.orcp.2024.09.275</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Since the adoption of billing codes for obesity, few studies have examined their use in administrative healthcare data. Of those that have, analyses have been limited to examinations of coding validity and trends among persons diagnosed with obesity (ICD-10, E66 code). This study aimed to explore the prevalence and predictors in E66 use across Canada two years prior to, and after the onset of Covid-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This secondary analysis used the 2018-2022 Discharge Abstract Dataset of the Canadian Institute for Health Information. The sample consists of 166,335 individuals 20 to 64 years old across all provinces/territories, excluding Québec. Prevalence of E66 was assessed for each province, and multivariable logistic regression analysis was used to estimate the odds of E66 coding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Regional variations were present in E66 use, with Manitoba having the highest prevalence of coding. Of those with a E66 code, 98.7 % were within the obesity BMI category. In general, females of higher age, with one or more comorbidities, and shorter length of stay had higher odds of receiving the E66 code. Odds of E66 coding were also lower in females after the onset of Covid-19, whereas in males, only those with shorter length of hospital stay had consistently higher odds of diagnosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study offers new insight into E66 use across Canada, and points to the need for consistent acquisition of weight and height information, and the use of E66 coding within existing electronic medical records systems to inform inter-provincial care gaps for obesity-related care.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mirzadeh</LastName><ForeName>Parmis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>York University, School of Kinesiology and Health Science, Toronto, Canada. Electronic address: mirzadeh@yorku.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuk</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>York University, School of Kinesiology and Health Science, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wharton</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>York University, School of Kinesiology and Health Science, Toronto, Canada; Wharton Medical Clinic, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ardern</LastName><ForeName>Chris I</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>York University, School of Kinesiology and Health Science, Toronto, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Obes Res Clin Pract</MedlineTA><NlmUniqueID>101303911</NlmUniqueID><ISSNLinking>1871-403X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">International classification of disease</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Obesity diagnosis</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no competing financial or personal interests that could have appeared to influence the work reported in this paper. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>3</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>3</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39353811</ArticleId><ArticleId IdType="doi">10.1016/j.orcp.2024.09.275</ArticleId><ArticleId IdType="pii">S1871-403X(24)00390-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle>